Ergothioneine as an Antioxidant and Mitochondrial Protectant

Ergothioneine is often filed under "antioxidant," but it does not behave like the antioxidants most people know. Vitamin C, vitamin E, and glutathione are all readily consumed when they do their job, and they can, under the wrong conditions, even turn into mild pro-oxidants. Ergothioneine is different: because it exists as a stable thione rather than a reactive thiol, it does not auto-oxidize, does not readily generate damaging radicals of its own, and can be stored in cells as a standing reserve. It is a potent scavenger of the most dangerous reactive species — the hydroxyl radical, singlet oxygen, and peroxynitrite — a chelator of the transition metals that catalyze oxidative damage, and it concentrates in mitochondria, the cell's main source of reactive oxygen. This page explains that chemistry and cell biology, and then, honestly, marks the line between what has been shown in cells and animals and what has actually been demonstrated in people, which so far is limited to biomarker studies.

A Different Kind of Antioxidant: Thione vs Thiol
What Reactive Species It Neutralizes
Metal Chelation
Concentration in Mitochondria
Cytoprotection: The Paul & Snyder Findings
Sparing the Wider Antioxidant Network
Stress-Response Behavior: An Antioxidant on Standby
Human Supplementation and Biomarker Data
Honest Limits: Mostly Preclinical
Key Research Papers
Connections
Featured Videos

A Different Kind of Antioxidant: Thione vs Thiol

The sulfur-based antioxidants the body relies on most — glutathione, cysteine, and drugs like N-acetylcysteine — all work through a thiol group, a sulfur bonded to a hydrogen (–SH). Thiols are effective but chemically restless: they readily give up their hydrogen, auto-oxidize in air, form disulfide bonds, and can generate reactive thiyl radicals as an intermediate. That reactivity is what makes them useful, but it also makes them short-lived and, in the wrong context, capable of feeding oxidative chemistry rather than quenching it.

Ergothioneine carries its sulfur on the imidazole ring of a histidine backbone, and at the body's pH it sits almost entirely in the thione form — the sulfur is double-bonded to carbon rather than dangling as a free –SH. The thione is far more stable. It resists auto-oxidation, does not readily produce reactive intermediates of its own, and has a redox behavior that lets it neutralize aggressive oxidants without becoming an aggressor in turn. This is the chemical basis for ergothioneine's two signature traits: it is unusually long-lived in tissue, and it is remarkably non-toxic even at high concentrations.

Back to Table of Contents

What Reactive Species It Neutralizes

Not all reactive oxygen and nitrogen species are equally dangerous. The body actually uses some of them — hydrogen peroxide, for instance, doubles as a signaling molecule. The truly destructive ones are the highly reactive species that attack whatever they touch, and these are exactly the ones ergothioneine is good at handling. Across cell-free chemistry and cell studies, ergothioneine has been shown to neutralize:

The hydroxyl radical (•OH) — the single most destructive oxidant in biology, which indiscriminately shreds DNA, lipids, and proteins. Ergothioneine is an efficient hydroxyl-radical scavenger.
Singlet oxygen — a high-energy form of oxygen generated by light exposure and inflammation, particularly damaging in the skin and eye.
Peroxynitrite (ONOO–) — formed when nitric oxide meets superoxide, a key player in inflammatory and vascular damage.
Hypochlorous acid (HOCl) — the bleach-like oxidant produced by activated immune cells, useful against microbes but harmful to host tissue in excess.

Notably, ergothioneine is not an especially strong scavenger of the milder, everyday radicals; its value is concentrated on the aggressive species that other antioxidants struggle to control. Barry Halliwell — one of the founders of the entire field of free-radical biology — and his collaborator Irwin Cheah have argued in several reviews that this targeting profile, combined with its stability and tissue localization, is what makes ergothioneine biologically interesting rather than just another antioxidant on a supplement label.

Back to Table of Contents

Metal Chelation

Much of the worst oxidative damage in the body is not caused directly by radicals floating free, but is catalyzed by loose transition metals — particularly iron and copper. Through the Fenton reaction, a free iron or copper ion can convert relatively harmless hydrogen peroxide into the ferociously reactive hydroxyl radical, right next to the DNA or membrane the metal happens to be bound to.

Ergothioneine can chelate divalent metal cations such as copper(II), effectively putting a leash on them so they cannot drive Fenton chemistry. This "preventive" antioxidant action — stopping the radical from ever forming — is often more valuable than mopping up radicals after the fact, and it complements the roles of dedicated metal-handling proteins and other dietary antioxidants. It also helps explain why ergothioneine concentrates in red blood cells and the eye lens, both metal-rich, oxygen-rich environments where uncontrolled metal-catalyzed oxidation would be especially harmful.

Back to Table of Contents

Concentration in Mitochondria

Mitochondria are the cell's power plants and, unavoidably, its main source of reactive oxygen: a small fraction of the electrons flowing through the respiratory chain leak out and form superoxide. Mitochondrial DNA sits close to this radical source, lacks the protective histone packaging of nuclear DNA, and is therefore especially vulnerable — mitochondrial damage is a central theme in most theories of aging.

Several studies report that ergothioneine accumulates inside mitochondria, positioning it precisely where the reactive oxygen is generated. Work from Bindu Paul and Solomon Snyder, and later reviews, describe ergothioneine protecting mitochondrial function and mitochondrial DNA under oxidative stress. The picture that emerges is of an antioxidant strategically stationed at the cell's most dangerous fire — not diffusing uselessly through the cytoplasm, but stockpiled in the mitochondrion and at other high-risk sites by the OCTN1 transporter described on the longevity-vitamin page. Other mitochondria-targeted antioxidants such as CoQ10 and alpha-lipoic acid share this logic of concentrating defense where oxidative load is highest.

Back to Table of Contents

Cytoprotection: The Paul & Snyder Findings

A landmark 2010 study by Bindu Paul and Solomon Snyder, published in Cell Death & Differentiation, gave ergothioneine its reputation as a "physiologic cytoprotectant." Working with cells, they showed that ergothioneine protected against oxidative-stress-induced death, and that when they blocked the OCTN1 transporter so cells could not take ergothioneine up, those cells became markedly more vulnerable to oxidative injury. The protection depended on the cell's ability to import and retain ergothioneine — strong evidence that the transporter and the molecule form a functional unit built for defense.

Snyder's laboratory is one of the most respected in neuroscience, and their framing — that ergothioneine is a nutrient the body deliberately accumulates to guard against oxidative and inflammatory damage — set the agenda for much of the research that followed. Subsequent work extended the cytoprotection theme to models of ischemia (restricted blood flow), inflammation, and neuronal injury, though, as the honest-limits section stresses, most of this remains at the cell and animal stage.

Back to Table of Contents

Sparing the Wider Antioxidant Network

Antioxidants do not work alone; they operate as a network that regenerates one another. Vitamin C can regenerate oxidized vitamin E; glutathione can regenerate vitamin C; and so on. Because ergothioneine is stable and handles the most aggressive oxidants, one proposed role is that it takes the "first hit" from dangerous species, sparing the more easily depleted members of the network — vitamin C, vitamin E, and glutathione — so they remain available for their own jobs.

There is also interest in the interplay between ergothioneine and selenium-dependent and glutathione-dependent enzymes, and in whether ergothioneine helps maintain overall cellular redox balance rather than acting through any single reaction. This "network sparing" idea is attractive and biochemically reasonable, but it is worth flagging that it is easier to demonstrate in a test tube than to prove matters for human health — a recurring theme with ergothioneine.

Back to Table of Contents

Stress-Response Behavior: An Antioxidant on Standby

One of the most intriguing features of ergothioneine is how the body deploys it. Rather than being consumed steadily, it appears to be held in reserve and mobilized when stress rises. Cells increase OCTN1 expression — and therefore ergothioneine uptake — under oxidative and inflammatory conditions. Tissues that are injured or inflamed accumulate more of it. This has led researchers to describe ergothioneine as a nutrient the body pre-positions in anticipation of trouble, a kind of standing antioxidant reserve that is drawn down only under duress.

This behavior distinguishes it sharply from the "use it and lose it" antioxidants and fits the longevity-vitamin framing: a compound the body values enough to hoard, retain for weeks, and reach for specifically when cells are under attack. It also raises a subtle interpretive challenge for the human studies — because stress and illness change ergothioneine handling, a low blood level in a sick person may partly reflect redistribution into damaged tissues rather than a simple dietary shortfall.

Back to Table of Contents

Human Supplementation and Biomarker Data

The most important human study to date is the 2017 report by Irwin Cheah and colleagues in Antioxidants & Redox Signaling, which gave purified ergothioneine to healthy volunteers. The key findings were pharmacological rather than clinical:

Oral ergothioneine was well absorbed, and blood levels rose substantially and then declined only slowly over subsequent weeks — confirming the long retention seen in animals.
Very little was lost in urine, indicating the body held onto most of what was absorbed.
There were trends toward lower levels of several biomarkers of oxidative damage and inflammation, consistent with an antioxidant effect — but this was a small study measuring biomarkers, not a trial measuring disease outcomes.
No adverse effects or toxicity were observed.

An earlier study by Weigand-Heller and colleagues (2012) similarly found that ergothioneine from mushrooms was bioavailable and raised blood antioxidant capacity acutely. Together these establish that dietary and supplemental ergothioneine reliably reaches the bloodstream and is retained — a necessary foundation for any health claim — but they stop well short of demonstrating that it prevents or treats any disease.

Back to Table of Contents

Honest Limits: Mostly Preclinical

It is important to be clear-eyed about where this science stands:

The chemistry is solid. That ergothioneine scavenges hydroxyl radicals, singlet oxygen, and peroxynitrite, chelates metals, and resists auto-oxidation is well established in the laboratory.
The cell and animal biology is compelling. Cytoprotection, mitochondrial localization, and stress-responsive accumulation are reproducible findings.
The human clinical evidence is thin. We have pharmacokinetic and biomarker studies, not outcome trials. Whether ergothioneine's antioxidant activity translates into fewer heart attacks, less cognitive decline, or longer healthspan in people remains genuinely unproven.
Antioxidant history counsels caution. Several antioxidants that looked excellent in the laboratory (isolated beta-carotene and high-dose vitamin E, for example) failed or even backfired in large human trials. Ergothioneine's different chemistry may spare it that fate — but that is a hope, not a result.

The reasonable position is enthusiasm tempered by patience: a biologically fascinating molecule with a strong mechanistic story, worth getting from a mushroom-rich diet, and worth watching as the first real clinical trials report.

Back to Table of Contents

Key Research Papers

Paul BD, Snyder SH (2010). The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death & Differentiation 17(7):1134–1140. — PubMed 19911007
Cheah IK, Halliwell B (2012). Ergothioneine; antioxidant potential, physiological function and role in disease. Biochimica et Biophysica Acta 1822(5):784–793. — PubMed 22001064
Halliwell B, Cheah IK, Tang RMY (2018). Ergothioneine — a diet-derived antioxidant with therapeutic potential. FEBS Letters 592(20):3357–3366. — PubMed 29851075
Cheah IK, Halliwell B (2021). Ergothioneine, recent developments. Redox Biology 42:101868. — PubMed 33558182
Cheah IK et al. (2017). Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation. Antioxidants & Redox Signaling 26(5):193–206. — PubMed 27488221
Weigand-Heller AJ, Kris-Etherton PM, Beelman RB (2012). The bioavailability of ergothioneine from mushrooms and the acute effects on antioxidant capacity and biomarkers of inflammation. Preventive Medicine 54 Suppl:S75–S78. — PubMed 22230474
Borodina I et al. (2020). The biology of ergothioneine, an antioxidant nutraceutical. Nutrition Research Reviews 33(2):190–217. — PubMed 32051057
Paul BD (2022). Ergothioneine: A Stress Vitamin with Antiaging, Vascular, and Neuroprotective Roles? Antioxidants & Redox Signaling 36(16–18):1306–1317. — PubMed 34619979
Gründemann D et al. (2005). Discovery of the ergothioneine transporter. PNAS 102(14):5256–5261. — PubMed 15795384